When considering 2028, people are scratching their heads, saying: What will I do then? In the meantime, physicians such as Moore and Weber hope the program will allow more patients to start taking a GLP-1
Clinical development of peptide therapies can also be complex and expensive, particularly when compounds have stability, delivery, or commercialization challenges
We included costs of lost earnings due to absenteeism (acute and chronic), workforce dropout due to CVD or ESKD, and loss of future earnings from premature mortality (death before retirement age, which was set at 67 years)
The company has also warned that products sold online under the retatrutide name may contain incorrect amounts, unknown ingredients, contaminants, impurities, or an entirely different substance